FogPharma (United States)

Recent papers from FogPharma (United States)

1. Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α Enabled by Automated Flow Peptide Synthesis TechnologyThe Journal of Organic Chemistry · 2024
2. Chemical Synthesis, Refolding, and Characterization of Mirror-Image Cyclophilin A2024
3. Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteinsNature Communications · 2024
4. Degradation of IKAROS prevents epigenetic progression of T cell exhaustion in a novel antigen-specific assay2024
5. Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α through the Synergy of Automated Flow Peptide Synthesis and Native Chemical Ligation2024
6. Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptidesNature Communications · 2023
7. AmberToolsJournal of Chemical Information and Modeling · 2023
8. De novo mapping of α-helix recognition sites on protein surfaces using unbiased librariesProceedings of the National Academy of Sciences · 2022
9. Exceptionally high-affinity Ras binders that remodel its effector domainJournal of Biological Chemistry · 2017
10. AOAC SMPR® 2017.001:Standard Method Performance Requirements (SMPRs) for Quantitation of Cannabinoids in Cannabis ConcentratesJournal of AOAC International · 2017
11. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet SyndromeNew England Journal of Medicine · 2017
12. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST ClinicJournal of Clinical Oncology · 2017
13. Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and TwoCannabis and Cannabinoid Research · 2017